Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle
Kidney Cancer Journal · 2021
DOI: 10.52733/kcj19n2-a2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Cancer Journal, 2021. Verfasst von Eric Lu und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Germline mutations in the fumarate hydratase (FH) and succinate dehydrogenase (SDH) genes lead to hereditary leiomyomatosis and RCC (HLRCC) and hereditary paraganglioma and pheochromocytoma, respectively. The renal cell carcinomas that arise in these conditions are characterized by dysregulated Krebs cycles, accumulation of oncometabolites, downstream changes in gene expression, and epigenetic modifications that carry unique therapeutic implications. In this review, we evaluate the current literature on these tumors, including the epidemiology, clinical course, screening guidelines, and management of localized and metastatic disease.
Zitieren
APA
Lu, E., Shuch, B., & Drakaki, A. (2021). Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle. Kidney Cancer Journal. https://doi.org/10.52733/kcj19n2-a2
Vancouver
Lu E, Shuch B, Drakaki A. Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle. Kidney Cancer Journal. 2021. doi:10.52733/kcj19n2-a2
BibTeX
@article{Lu2021,
author = {Lu, Eric and Shuch, Brian and Drakaki, Alexandra},
title = {Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle},
journal = {Kidney Cancer Journal},
year = {2021},
doi = {10.52733/kcj19n2-a2}
}
EUVIMED